Investigational drugs for the treatment of AD: what can we learn from negative trials?
about
Investigational drugs for the treatment of AD: what can we learn from negative trials?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@ast
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@en
type
label
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@ast
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@en
prefLabel
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@ast
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@en
P2860
P356
P1476
Investigational drugs for the treatment of AD: what can we learn from negative trials?
@en
P2093
Marwan N Sabbagh
Sandra A Jacobson
P2860
P2888
P356
10.1186/ALZRT73
P407
P577
2011-04-15T00:00:00Z
P5875
P6179
1028250531